Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Overview of Autism Spectrum Disorder
PDF (Portuguese (Brazil))

Keywords

Neurodevelopmental Disorders
Drug Therapy
Health Behavior

How to Cite

Overview of Autism Spectrum Disorder. (2026). Electronic Journal Collection Health, 26(2), e18882. https://doi.org/10.25248/reas.e18882.2026

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: Provide didactic updates on the definition, diagnosis, legislation, intervention, and new therapeutic targets for ASD. Bibliographic review: The Autism Spectrum Disorder (ASD) says respect to a meeting of neurobehavioral conditions, starting in early childhood, being characterized by the compromise of social skills and the presence of restrictive and repetitive behavioral patterns. It has a complex etiology, with interactions of genetic herdability and environmental influence, with an incidence of 1 in every 160 children in Latin America. The clinical picture of autism is aggravated by disorders associated with anxiety, irritability, attention deficit hyperactivity disorder (ADHD) or also sleep disorders. Final considerations: In the current scenario, only the behavioral disturbances associated with, the pharmacological risks linked to therapy for or treatment of ASD. Non-pharmacological practices have been shown to be positive in the best response to pharmacotherapy and in the best of social faculties. New studies aiming at more effective medications are being drawn up, with the expectation of significant improvement. Thus, it is not only in the therapeutic field, ASD, that we are gaining space, since the specific readings for autistic people are corroborated for the better quality of life and for the greater visibility of the disorder and its particularities.

PDF (Portuguese (Brazil))

References

AISHWORIYA R, et al. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics, 2022; 19(1): s13311-022-01183-1

AMERICAN PSYCHIATRIC ASSOCIATION. Manual Diagnóstico E Estatístico De Transtornos Mentais: DSM-5-TR. 5.ed. Porto Alegre: Artmed, 2023; 132-218p.

BÖLTE S, et al. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cellular and Molecular Life Sciences, 2018; 76(7): s00018-018-2988-4

BRASIL. LEI No 7.853, DE 24 DE OUTUBRO DE 1989. Disponível em: https://www.planalto.gov.br/ccivil_03/Leis/L7853.htm. Acesso em: 19 abril de 2024.

BRASIL. LEI No 8.742, DE 7 DE DEZEMBRO DE 1993. Disponível em: https://www.planalto.gov.br/ccivil_03/LEIS/L8742.htm. Acesso em: 19 abril de 2024.

BRASIL. LEI No 8.899, DE 29 DE JUNHO DE 1994. Disponível em: https://www.planalto.gov.br/ccivil_03/leis/l8899.htm. Acesso em: 21 abril de 2024.

BRASIL. Lei No 12.764, DE 27 DE DEZEMBRO DE 2012 Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12764.htm. Acesso em: 20 abril de 2024.

BRASIL. LEI No 13.370, DE 12 DE DEZEMBRO DE 2016. Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2015-2018/2016/lei/l13370.htm. Acesso em: 20 abril de 2024.

BRASIL. LEI No 13.977, DE 8 DE JANEIRO DE 2020 Disponível em: https://www.planalto.gov.br/ccivil_03/_Ato2019-2022/2020/Lei/L13977.htm. Acesso em: 20 abril de 2024.

BRASIL. LEI No 14.624, DE 17 DE JULHO DE 2023. Disponível em: https://www.planalto.gov.br/ccivil_03/_ato2023-2026/2023/lei/l14624.htm. Acesso em: 21 abril de 2024.

CDC. ESTADOS UNIDOS DA AMÉRICA. EUA. CENTERS FOR DISEASE CONTROL AND PREVENTION. Data & Statistics on Autism Spectrum Disorder. 2020. Disponível em: https://www.cdc.gov/ncbddd/autism/data.html. Acesso em: 20 março de 2024.

FREIRE MG, CARDOSO HSP. Diagnóstico do autismo em meninas: Revisão sistemática. Revista Psicopedagogia, 2022; 39(120): 2179-4057.20220033

FUSAR-POLI L, et al. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies. Brain Sciences, 2020; 10(9): brainsci10090572

GENOVESE A, BUTLER MG. Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD). International Journal of Molecular Sciences, 2020; 21(13): ijms21134726

GENOVESE A, BUTLER MG. The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations. Genes, 2023; 14(3): genes14030677

HODGES H, et al. Autism Spectrum Disorder: Definition, epidemiology, causes, and clinical evaluation. Translational Pediatrics, 2020; 9(1): tp.2019.09.09

ICD. CID-11 para Estatísticas de Mortalidade e Morbidade. 2022. Disponível em: https://icd.who.int/browse/2024-01/mms/pt#437815624. Acesso em: 11 março de 2024.

LAMPIASI N, et al. Inflammation and the Potential Implication of Macrophage-Microglia Polarization in Human ASD: An Overview. International Journal of Molecular Sciences, 2023; 24(3): ijms24032703

LI Y, et al. Fecal Microbiota Transplantation in Autism Spectrum Disorder. Neuropsychiatric Disease and Treatment, 2022; 18: ndt.s382571

LORD C, et al. Autism Spectrum Disorder. Nature Reviews Disease Primers, 2020; 6(1): s41572-019-0138-4

LUN T, et al. Acupuncture for children with autism spectrum disorder: A systematic review and meta-analysis. Medicine, 2023; 102(8): MD.0000000000033079

MELICIO RKISC, VENDRAMETTO O. Autista no Mercado de Trabalho. São Paulo: Blucher, 2021; 21-24p.

NANJAPPA MS, et al. Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review. CNS Spectrums, 2020; 27(3): s109285292000214x

OPAS. Transtorno do espectro autista - OPAS/OMS | Organização Pan-Americana da Saúde. Disponível em: https://www.paho.org/pt/topicos/transtorno-do-espectro-autista. Acesso em: 21 março de 2024.

PEDINI G, et al. Cancer drug repurposing in autism spectrum disorder. Trends in pharmacological sciences, 2023; 44(12): j.tips.2023.09.008

STYLES M, et al. Risk factors diagnosis prognosis and treatment of autism. Frontiers in Bioscience, 2020; 25(9): 4873

WANG L, et al. Autism Spectrum Disorder: Neurodevelopmental Risk Factors, Biological Mechanism, and Precision Therapy. International Journal of Molecular Sciences, 2023; 24(3): ijms24031819

XIONG M, et al. Efficacy of Melatonin for Insomnia in Children with Autism Spectrum Disorder: A Meta-analysis. Neuropediatrics, 2023; 54(3): s-0043-1761437